Corvus Pharmaceuticals (NASDAQ:CRVS) Q3 2026 Earnings Call
Corvus Pharmaceuticals (NASDAQ:CRVS) reports Q3 2026 results on this call. Live coverage runs here, and the full replay with transcript and chapters lands on this page after the call.
- Company
- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS)
- Period
- Q3 2026 earnings call
- Date
- Thu, Nov 5, 2026, 4:30 PM ET
On 6ix: 6ix.com/event/corvus-pharmaceuticals-inc-crvs-q3-2026-earnings-call
Latest news releases
- NASDAQ:CRVS — Corvus Pharmaceuticals to Provide Business Update and Third Quarter 2026 Financial Results on November 5, 2026 · Thu, Oct 29, 2026
- NASDAQ:CRVS — Corvus Pharmaceuticals Announces Initiation of Phase 1b Clinical Trial of Soquelitinib for Patients with Hidradenitis Suppurativa · Wed, Sep 30, 2026